MiniMed 780G system

Auto correction bolus to help prevent highs


“I was used to dealing with high sugar levels. Now, the system is working to keep them in check. It’s very freeing!”

Alexandra Park, actress and Medtronic partner living with type 1 diabetes


Learn more

 

Refers to SmartGuard feature. Individual results may vary.

Explore the MiniMed 780G system and learn more about how to start on insulin pump therapy.


MiniMed™ 780G system with SmartGuard™ technology
Smart devices sold separatelyΦ

Real-time insulin adjustments and corrections†† all day and night


Ever occasionally miss a meal dose or sometimes underestimate a carb count? Life with diabetes can be unpredictable.

Only the MiniMed 780G system with Meal Detection technology can automatically deliver correction boluses of insulin without any work needed from you, as quickly as every 5 minutes.

For those times when you forget to plan ahead. Just like in real life.


play video  Learn more


1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.

2. Individual results may vary.

3. dQ&A US Diabetes Patient Panel Report; Customer Overall Satisfaction, n=146; Q4 2023: P.52 (November 2023).



Features of the MiniMed 780G system


Auto correction icon

Auto correction

If your carb counts aren’t exact or if you occasionally miss a meal dose, the system automatically delivers a correction dose.
Compatible with the Medtronic Extended™ infusion set icon

Compatible with the Medtronic Extended™ infusion set

The first and only infusion set that can be worn for up to 7 days.
Personalized glucose targets icon

Personalized glucose targets

The only system with flexible glucose targets as low as 100 mg/dL.§
No-fingersticks icon

No fingersticksΩ with SmartGuard technology

The new Guardian 4 sensor sends sugar levels to the pump every 5 minutes with no fingersticks required when using SmartGuard technology.

Upgrade to the MiniMed 780G system

Complete the form to learn more from a diabetes therapy consultant.


Man playing tennis

Connor, T1D wearing the MiniMed™ 780G system


How can we communicate with you?

Ask more of your CGM

See how much more it can do as part of a system

See how the MiniMed 780G system works


The MiniMed 780G system is designed with SmartGuard technology, an advanced algorithm that uses current and past sugar level trends to anticipate, adjust, and correct insulin delivery.

 
Prevent highs and lows

Sugar levels trending high?

If your sugar levels are trending high, the system automatically gives you more insulin.


Sugar levels trending low?

If your sugar levels are trending low, the system automatically reduces the amount of insulin delivered.
 
New Meal Detection technology

Underestimate carb count before a meal?

Before you eat, enter the carb count into your pump. If the system detects a rapid rise of sugar levels, it automatically†† delivers stronger correction doses, up to every 5 minutes.


Miss a meal dose?

If you occasionally forget to give yourself a meal dose and you’re trending high, the system automatically delivers a correction dose to help bring you safely back to target.

MiniMed 780G system components

Insulin pump

Insulin pump

Based on info received from the CGM every 5 minutes, the pump makes automatic adjustments and corrections to your insulin delivery.

Left arrow Right arrow
Continuous Glucose Monitor (CGM)

Continuous glucose monitor (CGM)

The Guardian 4 sensor measures sugar levels every 5 minutes, sending levels to the pump. There are also no fingersticks with SmartGuard technology.Ω

Left arrow Right arrow
Infusion set

Infusion set

Allows for continuous and discreet delivery of insulin through a thin, flexible tube and can be worn up to 7 days.

Left arrow Right arrow
Smartphone app

Smartphone app

Get notified of highs and lows with the MiniMed Mobile app. Care partners can download the CareLink Connect app to stay in the know.

Left arrow Right arrow
Apple<sup>®</sup> Watch integration

Apple® smart watchΦ

Get alerts for highs or lows directly to your Apple® smart watch with the MiniMed Mobile app.

Left arrow Right arrow
780G features background image

My Insights
Powered by you.
Personalized by you.


Learn more
Exclusively for individuals using the MiniMed 700 series insulin pump and Guardian sensors, My Insights is a monthly dashboard that shares personalized insights like you've never seen before! When you enroll, you get:

  • Your latest Time in Range trends
  • Personalized opportunities from your data
  • Motivation and achievement badges
  • Unique support resources

Real people. Real experiences.

Our advanced technology ensures you have the confidence to navigate your own unique diabetes journey.


With the MiniMed 780G system, I sleep through the night. I haven’t done that in years."

Alexandra, Actress and #MedtronicChampion

Paid partnership. Compensated for her time. Thoughts and opinion are her own. Individual results may vary.
The MiniMed 780G system gives me more freedom."

Allison, #MedtronicChampion

Compensated for her time. Thoughts and opinion are her own. Individual results may vary.

Product comparison


See the difference between the MiniMed 780G system and our other insulin pumps.

Automated insulin delivery systems MiniMed<sup>™</sup> 780G system
MiniMed 780G system
  MiniMed<sup>™</sup> 770G system
MiniMed 770G system
  MiniMed<sup>™</sup> 670G system
MiniMed 670G system
Automatically corrects highs if carb counts are miscalculated or a bolus is occasionally missed
Automatically corrects highs if carb counts are miscalculated or bolus is occasionally missed icon green check
Personalize glucose targets ranges with the help of your HCP (100, 110, and 120 mg/dL)
Personalize glucose targets ranges with the help of your HCP (100, 110, and 120 mg/dL) icon green check
Enabled for future innovations via remote software updates
Enabled for future innovations via remote software updates icon green check icon green check
Compatible with latest Guardian™ 4 sensor — no fingersticks with SmartGuard technology
Compatible with latest Guardian™ 4 sensor - no fingersticks with SmartGuard technologyΩ icon green check
Automatically adjusts insulin delivery every 5 minutes to stabilize sugars
Automatically adjusts insulin delivery every 5 minutes to stabilize sugars icon green check icon green check icon green check
Average time in SmartGuard4 technologyΩ
Average time in SmartGuard4 technologyΩ 95% 87.5% 80.5%
Track your sugar levels on your Apple WatchΦ
Track your sugar levels on your Apple WatchΦ icon green check
You and caregivers can view your sugar trends on your smartphones
You and caregivers can view your sugar trends on their smartphone icon green check icon green check

Easy-to-use smartphone apps help you stay in the know


MiniMed mobile app icon
MiniMed Mobile app for people living with diabetes

View your diabetes data on your smartphone or Apple® smart watch, so you can easily track your glucose levels and get notified if you’re trending high or low. The app also enables automatic uploads of pump and CGM data to CareLink software.

Available to download at no cost for most iOS and Android smartphones.


  • Time in target range
    Average glucose value
    Smartphone showing the MiniMed mobile app
  • Current glucose reading
    Insulin delivery history
    Glucose trend over time
    Smartphone showing the MiniMed mobile app

MiniMed Mobile App in App Store MiniMed Mobile App in Google Play


CareLink connect app icon
CareLink Connect app for care partners

This app helps keep care partners in the loop. Securely invite up to 5 people to view insulin pump and sensor data, receive high and low notifications, and more.

Available to download at no cost for most iOS and Android smartphones.


  • Time in target range
    Average glucose value
    Smartphone showing time in range on the MiniMed mobile app
  • Current glucose reading
    Insulin delivery history
    Glucose trend over time
    Smartphone showing time in range on the MiniMed mobile app

Carelink Connect App in App Store Carelink Connect App in Google Play
  • Time in target range
    Average glucose value
    Smartphone showing the MiniMed mobile app
    Smartphone showing time in range on the MiniMed mobile app
  • Current glucose reading
    Insulin delivery history
    Glucose trend over time
    Smartphone showing the MiniMed mobile app
    Smartphone showing time in range on the MiniMed mobile app

App Store® online store is a service mark of Apple Inc.
"Google Play" is a property of Google LLC.

Support every step of the way


As your partner in care, we are here to help throughout the journey.


Hands-on product
training

Hands-on product training
In-person or online trainings help you get started on the right foot and make sure you have everything you need to be successful on your new therapy.

24-Hour Technical
Support

24-Hour Technical Support
We offer round-the-clock support for when you may need it. Call 1-800-646-4633 and select option 1.

Online educational
resources

Online educational resources
We're here to support you by offering a variety of online training resources.


Footnotes
Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
†† Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
Refers to SmartGuard feature. Individual results may vary.
§ Glucose targets should be chosen following a consultation with your healthcare provider.
Ω Fingersticks required in manual mode and to enter SmartGuard. If symptoms don’t match alerts and readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.
Φ Smart devices sold separately. For a list of compatible devices, visit http://bit.ly/CheckDevices.

References
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.
2. Individual results may vary.
3. dQ&A US Diabetes Patient Panel Report; Customer Overall Satisfaction, n=146; Q4 2023: P.52 (November 2023).
4. Carlson, A.L. et al. (2022) “Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes,” Diabetes Technology & Therapeutics, 24(3), pp. 178–189.


PROGRAMS TERMS AND CONDITIONS:

A. CGM Pathway Program

  • The Continuous Glucose Monitor (CGM) Pathway Program is for CGM transmitter upgrades only. CGM supplies and consumables are not included, unless otherwise stated.
  • Customers must have a Medtronic in-warranty transmitter to participate in the CGM Pathway Program.
  • Customers transitioning from one Medtronic CGM system will not have any upfront out-of-pocket costs to Pathway to another Medtronic CGM transmitter.
  • Upon completion of the transaction, customers will receive one (1) transmitter that is the latest technology compatible with their current pump system.
  • The CGM Pathway Program does not extend the warranty period of the replaced product. The customer’s current warranty timeline will not change by obtaining a CGM transmitter through this program.
  • Offer applies to a maximum of one (1) transmitter per customer and cannot be used in conjunction with the MiniMed™️ 780G System Program or Competitor CGM Pathway Program.
  • Customers who do not purchase supplies from Medtronic should call Medtronic to participate in the program. Ongoing supplies should continue to be purchased through current supply provider (distributor).
  • Certain labeling restrictions for MiniMed™️ CGM may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider regarding indications for use.
  • A valid prescription will be required to obtain a new CGM. Other restrictions may apply.
  • Customers should verify that their insurance provider will support transitioning to the new CGM, as it could affect ongoing coverage of their future CGM supplies.
  • This program is available to customers whose payers bill transmitters and sensors separately. Customers whose payers utilize a monthly CGM supply allowance are excluded from this program.
  • Customers will be able to receive up to two (2) boxes of Guardian™️ 4 sensors at no cost if Medtronic Guardian™️ Sensor 3 were purchased in the last 90 days.
  • Special restrictions apply for customers with commercial insurance residing in Massachusetts & Michigan and/or customers enrolled in any federal, state, or government-funded healthcare. Refer to special circumstances’ terms & conditions.
  • Kaiser health plans are excluded from this program.
  • Program terms and conditions are subject to change at any time and without notice.


B. MiniMed™️ 780G System Program

  • Offer is available until April 27, 2024 to existing Medtronic customers upgrading to or purchasing the MiniMed™️ 780G system with commercial insurance.
  • The MiniMed™️ 780G System Program is for CGM upgrades only. CGM transmitters and sensors are included with this transaction.
  • Customers must have an out-of-warranty transmitter (Medtronic or competitor) or no CGM to participate in the MiniMed™️ 780G System Program.
  • Customers will pay $100 out-of-pocket to purchase one (1) Medtronic Guardian™️ 4 CGM transmitter and one (1) 5-pack of Guardian™️ 4 sensors. A customer's insurance will not be billed for this initial order.
  • Customers will be able to receive up to two (2) boxes of Guardian™️ 4 sensors at no cost if Medtronic Guardian™️ Sensor 3 were purchased in the last 90 days.
  • Customers who do not purchase supplies from Medtronic should call Medtronic to participate in the program. Ongoing supplies should continue to be purchased through current supply provider (distributor).
  • Offer applies to a maximum of one (1) Guardian™️ 4 transmitter per customer and cannot be used in conjunction with the CGM Pathway Program or Competitor CGM Pathway Program.
  • Customers who decide not to continue with the Medtronic Guardian™️ 4 CGM have 60-days from date of purchase to initiate the refund process and Medtronic will refund the $100 out of pocket that was paid.
  • MiniMed™️ CGM have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider regarding indications for use.
  • A valid prescription will be required to obtain a new CGM. Other restrictions may apply.
  • Customers should verify that their insurance provider will support transitioning to the new CGM, as it could affect ongoing coverage of their future CGM supplies.
  • This program is only available to customers whose payers bill transmitters and sensors separately. Customers whose payers utilize a monthly CGM supply allowance are excluded from this program.
  • Customers with commercial insurance residing in Massachusetts & Michigan and/or customers enrolled in any federal, state, or government-funded healthcare are excluded from this program.
  • Kaiser & Excellus health plans are excluded from this program.
  • Program terms and conditions are subject to change at any time and without notice.


Important safety information: MiniMed 780G system with SmartGuard technology with Guardian 4 sensor

The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 780G system consists of the following devices: MiniMed 780G insulin pump, the Guardian 4 transmitter, the Guardian 4 sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to seven days of continuous use.

The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.

WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library